Covid-19 vaccine: Bharat Biotech confirms adverse event during Covaxin phase 1 trial reported within 24 hours
The adverse event occurred in a 35-year old participant with no co-morbidities, who was part of Phase 1 trials at a site in western India.
💡 newsR Knowledge: Other News Mentions
Jharkhand Police: ₹ 35 lakh as fine from masses violating Covid norms | Oneindia News
Credit: Oneindia Duration: 03:39Published
Covaxin effectively neutralises all key emerging variants, says study published in Oxford journalIndigenous Covid-19 vaccine Covaxin has been able to neutralise all key emerging variants, including the double mutant B.1.617 and B.1.1.7, which was first..
Get Bharat Biotech to share vaccine manufacturing tech with other WHO prequalified pharma cos: Ghulam Nabi Azad
Zee 24 Ghanta editor Anjan Bandyopadhyay dies in Kolkata due to COVID-19Family sources said that Anjan Bandyopadhyay had tested positive for COVID-19 in mid-April following which he was hospitalised.
Study: Covid deaths have affected 82% of elderly with anxietyLoneliness and a deepening sense of uncertainty has hit the senior citizens like never before during the second wave of Covid-19 pandemic, according to the..
Tauktae now ‘very severe’ cyclone, set to rip into Gujarat at 185kmphCovid-bruised Gujarat braced for a battering by the strongest cyclone to hit its coast since 1998 as Tauktae, which cut a swathe through the western coastal belt..
‘PM Cares helped triple number of ventilators’Ventilators allocated to states and Union Territories under PM Cares and the health ministry have more than tripled availability of the critical care machines in..
You Might Like
Related videos from verified sources